| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/02/2002 | CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease |
| 10/02/2002 | CN1372466A New use of docetaxel for treating hepatoma |
| 10/02/2002 | CN1371746A Chinese medicine composition with functions of regulating blood-liquid and curing chemical liver injury |
| 10/02/2002 | CN1371745A Medicine for removing hernia |
| 10/02/2002 | CN1371737A Chinese medicine specially effective for liver disease and preparation process |
| 10/02/2002 | CN1371726A Decocted pill medicine for treating excess syndrome of hepatitis B |
| 10/02/2002 | CN1371719A Smellting treated Chinese medicine |
| 10/02/2002 | CN1371714A Powder medicine for treating liver disease |
| 10/02/2002 | CN1371713A Yilidan Chinese patent medicine |
| 10/02/2002 | CN1371704A Medicine for treating digestive system disease and tumor and preparation method thereof |
| 10/02/2002 | CN1371702A Health care medicinal liquor and preparation method thereof |
| 10/02/2002 | CN1371700A Medicine for treating stomatocase |
| 10/02/2002 | CN1371695A Forest frog ovum oil soft capsule and production technology thereof |
| 10/02/2002 | CN1371688A Medicinal application of VC phosphate ester magnesium |
| 10/02/2002 | CN1371678A Method for preparing block type chewing taking type soft extract |
| 10/02/2002 | CN1371636A Brain health preserving liquid |
| 10/02/2002 | CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 10/02/2002 | CN1091595C Use of a compound in preparing medicine for curing dyspepsia |
| 10/01/2002 | US6459003 Ether compounds |
| 10/01/2002 | US6458951 For treatment of male erectile dysfunction, female sexual dysfunction |
| 10/01/2002 | US6458925 Peptide antagonists of zonulin and methods for use of the same |
| 10/01/2002 | US6458846 Ion channel modulating agents |
| 10/01/2002 | US6458844 Antiinflammatory agents |
| 10/01/2002 | US6458837 Lipophilic diesters of chelating agents |
| 10/01/2002 | US6458831 Matairesinol and (-)- wikstromol phenols together with or associated with therapeutically acceptable additives are useful as antioxidants and as free radical scavengers |
| 10/01/2002 | US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia. |
| 10/01/2002 | US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto |
| 10/01/2002 | US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| 10/01/2002 | US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer |
| 10/01/2002 | US6458810 Pharmaceutically active isoindoline derivatives |
| 10/01/2002 | US6458805 Antagonists; especially sodium salts |
| 10/01/2002 | US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated |
| 10/01/2002 | US6458777 Methods and compositions for treating and preventing mucositis |
| 10/01/2002 | US6458776 Inflammatory bowel disease |
| 10/01/2002 | US6458589 Hepatocyte lineage cells derived from pluripotent stem cells |
| 10/01/2002 | US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation |
| 10/01/2002 | US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
| 10/01/2002 | US6458364 Non-splicing variants of gp350/220 |
| 10/01/2002 | CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists |
| 10/01/2002 | CA2241845C 4,5-dihydronaphth¬1,2-c|isoxazoles and derivatives thereof having cns activity |
| 10/01/2002 | CA2228370C Piperazino derivatives as neurokinin antagonists |
| 10/01/2002 | CA2168113C Therapeutic peptide derivatives |
| 10/01/2002 | CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them |
| 09/26/2002 | WO2002074968A1 Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof |
| 09/26/2002 | WO2002074937A1 Method of differentiating immature liver cells by using extracellular matrix |
| 09/26/2002 | WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074806A2 New interferon beta-like molecules |
| 09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
| 09/26/2002 | WO2002074780A1 Chemical compounds |
| 09/26/2002 | WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/26/2002 | WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/26/2002 | WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use |
| 09/26/2002 | WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient |
| 09/26/2002 | WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity) |
| 09/26/2002 | WO2002074767A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074766A1 Method of preparing lansoprazole and its intermediate |
| 09/26/2002 | WO2002074761A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/26/2002 | WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 09/26/2002 | WO2002074752A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074751A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074750A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074749A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074748A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/26/2002 | WO2002074733A2 Tryptase-inhibitors |
| 09/26/2002 | WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6? |
| 09/26/2002 | WO2002074346A2 Targeting chemical compounds to cells |
| 09/26/2002 | WO2002074343A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 09/26/2002 | WO2002074334A1 Mycrobacterial extract and its use in inflammatory bowel disease |
| 09/26/2002 | WO2002074326A2 Urocortin-iii and uses thereof |
| 09/26/2002 | WO2002074316A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 09/26/2002 | WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors |
| 09/26/2002 | WO2002074309A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors |
| 09/26/2002 | WO2002074306A1 Remedies for fatty liver |
| 09/26/2002 | WO2002074302A1 Amino acid compositions for ameliorating liver failure |
| 09/26/2002 | WO2002074301A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/26/2002 | WO2002074299A1 TNFα PRODUCTION INHIBITORS |
| 09/26/2002 | WO2002074292A2 Hormone replacement therapy |
| 09/26/2002 | WO2002074275A2 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces |
| 09/26/2002 | WO2002074251A2 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | WO2002074238A2 Water soluble and palatable complexes |
| 09/26/2002 | WO2002074157A2 A mammalian immortalized liver cell |
| 09/26/2002 | WO2002074099A2 Polybutene containing chewing gum and confection |
| 09/26/2002 | WO2002074056A2 Allosteric adenosine receptor modulators |
| 09/26/2002 | WO2002074042A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 09/26/2002 | WO2002062999A8 Proteins and nucleic acids encoding same |
| 09/26/2002 | WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 09/26/2002 | WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof |
| 09/26/2002 | WO2002036116A3 Tripeptidyl peptidase inhibitors |
| 09/26/2002 | WO2002026954A3 Truncated phosphodiesterase-7 polypeptides |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002015918A3 Method and compositions for promoting osteogenesis |
| 09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 09/26/2002 | WO2001083775A3 Proteases |
| 09/26/2002 | WO2001076635A1 Preparations for preventing bile acid diarrhea |
| 09/26/2002 | WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |